• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.82% Nasdaq Up 2.46%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    92.42 Up 3.94(4.45%) 4:00PM EDT
    Add to Portfolio
    Prev Close:88.48
    Open:89.49
    Bid:92.16 x 100
    Ask:92.76 x 100
    1y Target Est:116.25
    Beta:0.053454
    Earnings Date:Oct 26 - Oct 30 (Est.)
    Day's Range:88.51 - 92.46
    52wk Range:41.99 - 112.40
    Volume:227,087
    Avg Vol (3m):424,009
    Market Cap:1.83B
    P/E (ttm):59.59
    EPS (ttm):1.55
    Div & Yield:0.46 (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    LGNDUp 4.45%1.83B
    MRKUp 0.86%149.23B
    LLYUp 2.52%86.64B

    Key Statistics

    Forward P/E (1 yr):29.62
    P/S (ttm):24.74
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-15) :2.86
    Quarterly EPS Est (Sep-15) :0.42
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):0.69

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback